Bulletin
Investor Alert

May 29, 2020, 5:50 a.m. EDT

Orthopedic Biomaterials Market To Be Worth US Dollor 26 Bn By 2027

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

May 29, 2020 (Global QYResearch via COMTEX) -- The global Orthopedic Biomaterials Market size is expected to reach USD 26 billion by 2027, at a significant growth rate of 10% during the forecasted period 2020 to 2027. The research report provides a big picture of “Orthopedic Biomaterials Market ” 2027, on a global basis, offering a forecast and statistic in terms of revenue during the forecast period 2020 to 2027. This report covers detailed segmentation, complete R & D history, and explanatory analysis including the latest news.

Get FREE SAMPLE PDF (Including Full TOC, Table & Figures)@ https://www.acumenresearchandconsulting.com/request-sample/1530

A major factor driving the market is the increased prevalence of degenerative joint diseases and musculoskeletal disorders. Moreover, the growing geriatric population, which is prone to orthopedic circumstances owing to low bone density and the development of illnesses associated with bone, is anticipated to increase the product supply over the forecast era.

Due to the increasing demands for these products owing to its elevated pressure intensity, ceramics & bioactive glass were the dominant product type category in 2018. Furthermore, ceramic & bioactive glass biomaterials have an excellent affinity to integrate with the surface material of the bone than their counterparts. Due to the high use of these materials for the reconstruction and fixation of the spine, hip and knee, the polymer biomaterial segment is expected to be the fastest CAGR between 2019 and 2026.

The implementation segment was resulted by orthopedic implants in 2018 and is anticipated to continue in dominance over the forecast period. One of the main variables driving development in this section is an increasing amount of instances of trauma. From 2019 to 2026, the fastest CAGR in the sector of orthobiology is expected to be 10.5%. Increasing use of biomaterial for spinal and other reconstructive surgeries in different orthobiological applications is expected to lead to development in this section.

A increasing market in America is the North American market in orthopedic biomaterials. The region of America is divided into North America and South America on a regional basis. The US and Canada are divided into North America. The growing incidence of various orthopedic procedures, along with the growing elderly population, is likely to speed up the market. In addition, increased awareness of biodegradable products, increased healthcare and rising demand for sophisticated medicines and products, together with increased public assistance, is probable to increase the development of North America’s orthopedic biomaterials industry. For example, in 2016, around 1.61.040 joint substitution procedures took place in the United States, according to the American Joint Replacement Registry.

The fastest-growing market is anticipated in Asia Pacific. The increase in chronic diseases is the main driving force behind the development of the industry. As the population increases, China is the fastest growing area due to an increasing number of patients. The market in this region is driven by increasing awareness of the safety and access to fresh therapy techniques. The development of the biomaterial orthopedics industry in Asia-Pacific is driven by higher healthcare expenses and increased living standards.

Middles of consciousness, restricted access, and the accessibility of therapy services are anticipated to demonstrate the slower development in the market for the Middle East and Africa. Due to the increased health care spending and the general development in the healthcare situation, the United Arab Emirates is the biggest market in the Middle East.

View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/orthopedic-biomaterials-market

Key Highlights

Due to a big patient pool and elevated awareness of the use of biologically absorbable biomaterials, North America accounted for the biggest income share in 2018.

Due to the enhanced use of this biomaterial for the reconstruction of the damaged tissue and fixation surgeries and joint replacement surgery, ceramics and the bioactive glass segment resulted the market in 2018.

Due to an increase in the world’s trauma instances, orthopedic implants were the most important application category in 2018.

Key Players & Strategies

With a few smaller respondents, the worldwide sector is oligopolistic in nature. Some vital companies operating in this market include DePuy Synthes Inc.; DSM Biomedical; Stryker Corp.; Invibio Ltd.; AdvanSource Biomaterials Corp.; Zimmer Biomet; Globus Medical; Matexcel; Exactech, Inc.; CAM Bioceramics B.V.; Evonik Industries AG; and Heraeus Holding.

The report is readily available and can be dispatched immediately after payment confirmation.

Download This Premium Research Report (Single User License US$ 4500)@ https://www.acumenresearchandconsulting.com/buy-now/0/1530

About Acumen Research and Consulting:

1 2
This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.